Author:
Cook Natalie,Basu Bristi,Biswas Swethajit,Kareclas Paula,Mann Colette,Palmer Cheryl,Thomas Anne,Nicholson Steve,Morgan Bruno,Lomas David,Sirohi Bhawna,Mander Adrian P.,Middleton Mark,Corrie Pippa G.
Reference10 articles.
1. Management of cutaneous melanoma;Tsao;N Engl J Med,2004
2. A randomized phase 2 trial of bevacizumab with or without daily low-dose interferon alfa-2b in metastatic malignant melanoma;Varker;Ann Surg Oncol,2007
3. Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis;Eisen;Br J Cancer,2006
4. Axitinib (AG-013736) in patients with metastatic melanoma: a phase II study;Fruehauf;J Clin Oncol,2008
5. PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration;Wood;Cancer Res,2000
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献